Rosacea cream Iverlit

Iverlit cream contains Ivermectin , 1%.

DESCRIPTION:

• Has an anti-inflammatory effect.
• Eliminates redness and itching.

Appointment:

• Skin care for papulopustular rosacea.
• It is used for skin lesions caused by Demodex mites to eliminate symptoms of inflammation and acne.

METHOD OF USE:

• It is applied once a day.
• Before use, wash the skin thoroughly with water or a mild cosmetic cleanser and dry completely.
• Apply a pea-sized amount of cream to each of the five areas of the face: forehead, chin, nose and both cheeks .
• Spread a thin layer over the skin of the face.
• Avoid contact with eyes, lips and mucous membranes.
• After applying the cream, you should wash your hands.
• Decorative cosmetics can be applied only after the cream has dried.

Recommendations for use:

• Do not use if you are allergic or hypersensitive to any of the components.
• Iverlit cream is well tolerated and usually does not cause unwanted effects.
• If during use you experience skin irritation (dryness, burning, itching, exacerbation of rosacea, erythema, contact dermatitis, swelling, etc.), you should reduce the frequency of use and/or the amount of cream and consult a doctor. If necessary, discontinue use of the product.
• Do not use orally, vaginally, on mucous membranes, open wounds, or burns.
• Not recommended for use during pregnancy or breastfeeding due to lack of data on the safety of such use.
• For use by adults over 18 years of age.

FULL Composition:

Ivermectin 1%, cetostearyl alcohol, light liquid paraffin, white soft paraffin, Ginolic CSA (CM-1000), propylene glycol, hard paraffin wax, glyceryl monostearate, glycerin, ethylenediamine tetraacetic acid, sodium methylparaben, sodium propylparaben, butylated hydroxytoluene, citric acid, water.

Iverlit cream . Conclusion DSEE No. 12.2-18-3/7218 dated 11/17/2022. Not a medicinal product . Advertising of a cosmetic product . Full information is contained in the instructions for use of the cosmetic product . Before use, be sure to read the instructions for use of the cosmetic product and consult a doctor. Keep out of the reach of children. Manufacturer. Elegant Cosmed Pvt. Ltd., Plot No.-32 & 33, GIDC Kuvadava, Rajkot-360023, Gujarat, India. Contacts: e legantcosmed.com. Official distributor. AVIM GROUP LLC, Kyiv, Oleksiyivska 3, tel. 044-361-33-65

Sometimes you want to forget that you have this unpleasant disease... But even if you don't look in the mirror, you won't be able to forget... After all, you feel tingling, burning, swelling on your face, sometimes mild unpleasant sensations, and sometimes heat... But the unpleasant sensations seem to have passed and you run to the mirror to make sure that the disease is gone, but no... You see your reddened skin again and this unpleasant rash in the form of pimples, which is so reminiscent of teenage rashes... This is a papulopustular form of rosacea - this is the diagnosis made by the doctor.

What to do and what to use with such a diagnosis? One of the drugs that has been shown to be highly effective in rosacea in numerous studies is Ivermectin. Since the Demodex mite can be the cause of rosacea, and Ivermectin has an antiparasitic effect, its use is really effective in rosacea. Ivermectin also has anti-inflammatory activity. It is not an antibiotic, so it does not develop addiction and can be used for a long time - from several months to a year. In addition to its high effectiveness, Ivermectin, being a safe drug, demonstrates good tolerability. Taking into account all these factors, Ivermectin was included in the treatment protocols for rosacea.

Sources and literature used:

• And instructions for using the cosmetic product Iverlit cream.
• Edge Zuuren et al., Phenotypic-based interventions for rosacea: an updated systematic review including GRADE assessments ; British Journal of Dermatology, Volume 181, Issue 1, July 1, 2019, pages 65–79.
• Chiel Cristiano F. Ebbelar et al; Topical ivermectin in the treatment of papulopustular rosacea: a systematic review of the evidence and clinical recommendations; Dermatology and Therapeutics, Issue 8, 2018; pp. 379–387; published 25.06.2022.
• K. Prykhodko-Dybska; Rosacea: updated recommendations; Ukrainian Medical Journal, 2020-07-03.
• Caroleite Helwick; Perspectives in Dermatology – Rosacea ; Journal of Rosacea ; published June 27 , 2014 ; https://www.ahdbonline.com/payer-perspectives-in-dermatology/1803-novel-rosacea-compound-ivermectin-cream-offers-unique-mechanism-of-action
• Martin Schaller et al., Department of Dermatology, University Hospital Tübingen, Tübingen, Baden-Württemberg, Germany; The importance of assessing burning and tingling in the treatment of rosacea: a review; October 13, 2021; https://medicaljournalssweden.se/actadv/article/view/356/750
• Kashif Siddiqui et al; Efficacy, safety, and tolerability of ivermectin compared with current topical treatments for inflammatory rosacea lesions: a network meta-analysis; Springer Plus, Issue 5, Articles: 1151 (2016).